NASDAQ: MLTX MoonLake Immunotherapeutics 8-K

MoonLake shareholders approve 5M share increase to equity compensation plan

Filed June 9, 2026 · Period ending June 4, 2026 · ~1 min read

Key Changes

  • medium

    Shareholders approved adding 5 million Class A shares to the 2022 Equity Incentive Plan, increasing the pool available for employee stock compensation and extending the plan through 2036.

  • medium

    The amended plan removes liberal share recycling provisions that previously allowed reuse of forfeited shares, potentially limiting future dilution from canceled awards.

  • low

    New one-year minimum vesting requirement added for equity awards, preventing immediate vesting of stock compensation grants to employees and directors.

2 more material changes plus the full narrative summary — create a free account to see the rest. Takes 30 seconds.

Partner

Trade MLTX commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Generated by AI · Jun 10, 2026 4:10 PM